Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.4% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

2 recruiting

Enrollment reporting

Analytics

Phase 2/3
1(25.0%)
Phase 4
1(25.0%)
Phase 2
1(25.0%)
Early Phase 1
1(25.0%)
4Total
Phase 2/3(1)
Phase 4(1)
Phase 2(1)
Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT07790744Recruiting

A Comprehensive, Multimodal Characterization of Prodromal PD in Subjects With RBD

Role: collaborator

NCT04105231Phase 2Active Not Recruiting

Cannabidiol for Treatment of Non-affective Psychosis and Cannabis Use

Role: collaborator

NCT06062953Phase 2/3Recruiting

Efficacy of Melatonin, Low-dose Quetiapine, or Placebo in Patients With Psychiatric Disorders and Comorbid Insomnia

Role: collaborator

NCT05762783Completed

The Importance of Sleep for Diabetes Associated Tasks and Outcomes

Role: collaborator

NCT03535636Completed

Sleep Impairments in Refugees Diagnosed With PTSD

Role: collaborator

NCT03576664Early Phase 1Completed

Effects of Sleep Deprivation and Adrenergic Inhibition on Glymphatic Flow in Humans

Role: collaborator

NCT02761161Phase 4Completed

Treatment of Sleep Disturbances in Trauma-affected Refugees

Role: collaborator

All 7 trials loaded